| |
|
|
|
Pacific Biosciences  
|
|
31.06 -1.82 (-0.06%) |
01-27 16:00 |
|
Open: |
30.91 |
Pre close: |
32.88 |
Target:
|
48.65
|
|
High: |
32.99 |
Low: |
28.75 |
Resistance:
|
41.65
48.65
|
|
Volume: |
5,617,946 |
Market Cap: |
5815M |
Support:
|
28.18
19.85
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
34.72
 |
MACD |
MACD(12,26):
|
2.98 |
|
MA(20): |
32.94  |
Signal(12,26,9): |
3.78 |
|
MA(100): |
18.20 |
Stochastic Oscillator |
%K(14,3):
|
46.64 |
|
MA(250): |
9.63 |
%D(3): |
59.74 |
|
Average Volume(K) |
3-Month: |
511020
|
52-Week |
High:
|
41.65 |
|
10-Days: |
521962 |
Low: |
2.20 |
|
RSI |
RSI(14):
|
49.89 |
Change(%): |
562.3 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.290 |
Return on Equity (ttm) |
-50.5 |
Shares Out. (M) |
187.22 |
|
EPS Est. Current Year |
-0.890 |
Return on Assets (ttm) |
-27.2 |
Shares Float (M) |
178.29 |
|
EPS Est. Next Year |
-0.640 |
PEG Ratio |
0.00 |
% Held by Insiders |
2.76 |
|
EPS Est. Next Quarter |
-0.180 |
Qtrly Rev. Growth |
-12.9 |
% Held by Institutions |
94.62 |
|
Forward EPS |
-0.550 |
Gross Profit (p.s.) |
0.185 |
Shares Short (K) |
11940 |
|
Book Value (p.s.) |
0.720 |
EBITDA (p.s.) |
-0.483 |
P/E |
-107.10 |
|
Sales Per Share |
0.426 |
Qtrly Earnings Growth |
0.00 |
P/BV |
43.14 |
|
Profit Margin |
-57.25 |
Operating Cash Flow
(M) |
15.59 |
P/S |
72.97 |
|
Operating Margin |
-121.76 |
Levered Free Cash Flow
(M) |
55.11 |
P/CF |
373.00 |
|
|
|
|
|
|
